IMAC Holdings, Inc. (NASDAQ:BACK – Get Free Report) major shareholder Jorge Ruiz purchased 164,872 shares of the firm’s stock in a transaction that occurred on Friday, March 22nd. The stock was bought at an average price of $3.58 per share, for a total transaction of $590,241.76. Following the transaction, the insider now directly owns 164,872 shares of the company’s stock, valued at $590,241.76. This trade represents a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.
IMAC Stock Down 4.2 %
NASDAQ BACK traded down $0.03 on Friday, hitting $0.58. 124,923 shares of the company’s stock were exchanged, compared to its average volume of 643,424. The stock has a 50-day moving average of $0.84 and a 200-day moving average of $1.10. IMAC Holdings, Inc. has a 52 week low of $0.47 and a 52 week high of $7.75.
IMAC (NASDAQ:BACK – Get Free Report) last announced its quarterly earnings data on Friday, January 17th. The company reported ($1.33) earnings per share for the quarter.
About IMAC
IMAC Holdings, Inc owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains.
See Also
- Five stocks we like better than IMAC
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Rubrik Stock’s V-Bottom Reversal Signals a Major Rally Ahead
- Consumer Staples Stocks, Explained
- How Super Micro Computer Stock Is Defying the Market Sell-Off
- Investing in Travel Stocks Benefits
- AppLovin vs. HPE: Which Tech Stock Can Bounce Back Faster?
Receive News & Ratings for IMAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMAC and related companies with MarketBeat.com's FREE daily email newsletter.